Ryan Potts

Vice President, Research Amgen Inc.

Wednesday 28th October 2026

Panel Discussion: Shaping Investment in Induced Proximity: Insights to Accelerate Development & Secure Funding

9:30 am

Exploring the data, targets, and indications investors are prioritizing to support next-generation induced proximity therapeutics
Discussing funding strategies for early-stage companies, including milestones needed to secure investment and attract pharmaceutical partnerships
Evaluating how scientific innovation and emerging modalities influence investor confidence and the types of assets and platforms likely to attract investor interest

Tuesday 27th October 2026

Panel Discussion: Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact

9:00 am

Examining recent advances across degrader and non-degrader modalities, highlighting how new discoveries are moving the field beyond oncology
Assessing the influence of global markets, including China, on drug development, the clinical landscape and strategic collaborations in induced proximity therapeutics
Identifying emerging opportunities, bottlenecks, and the next frontiers in translating platform innovations into clinically relevant therapies

Tuesday 27th October 2026

Chair’s Opening Remarks

8:20 am

Wednesday 28th October 2026

Chair’s Opening Remarks

8:20 am

Tuesday 27th October 2026

Beyond Degraders: Are We Asking the Wrong Questions in Induced Proximity?

9:30 am